Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
24.80
+0.53 (2.18%)
At close: Oct 29, 2026, 4:00 PM EDT
25.00
+0.20 (0.81%)
After-hours: Oct 29, 2026, 7:20 PM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $2.81 billion as of October 29, 2026. It is the 5,387th most valuable company in the world and the 1,569th biggest in the United States. Its market cap has increased by 48.49% in one year.
Market Cap
2.81B
Enterprise Value
2.07B
1-Year Change
48.49%
Global Rank
Country Rank
#1,569 United States
Category
ChartMarket Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $2.81B, an increase of 7,996.97%. That is a compound annual growth rate of 42.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 2.81B | -5.41% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 3.24B |
| Viking Therapeutics | 3.20B |
| Denali Therapeutics | 3.11B |
| Nurix Therapeutics | 3.02B |
| Beam Therapeutics | 2.92B |
| Arcus Biosciences | 2.70B |
| MBX Biosciences | 2.67B |
| Recursion Pharmaceuticals | 2.56B |